162 related articles for article (PubMed ID: 20358434)
1. A Bayesian measurement error approach to QT interval correction and prolongation.
Chen J; Zhao X
J Biopharm Stat; 2010 May; 20(3):523-42. PubMed ID: 20358434
[TBL] [Abstract][Full Text] [Related]
2. Statistical characterization of QT prolongation.
Schall R; Ring A
J Biopharm Stat; 2010 May; 20(3):543-62. PubMed ID: 20358435
[TBL] [Abstract][Full Text] [Related]
3. A nonparametric approach to QT interval correction for heart rate.
Wang D; Cheung YB; Arezina R; Taubel J; Camm AJ
J Biopharm Stat; 2010 May; 20(3):508-22. PubMed ID: 20358433
[TBL] [Abstract][Full Text] [Related]
4. QT analysis: a complex answer to a 'simple' problem.
Li L; Desai M; Desta Z; Flockhart D
Stat Med; 2004 Sep; 23(17):2625-43. PubMed ID: 15316947
[TBL] [Abstract][Full Text] [Related]
5. Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QTc prolongation.
Malik M; Hnatkova K; Batchvarov V
Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):791-800. PubMed ID: 15189536
[TBL] [Abstract][Full Text] [Related]
6. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
7. Multiple comparisons of repeated measured response: issues of assessment of prolongation of QT interval in thorough QT trials.
Tsong Y; Zhong J
J Biopharm Stat; 2010 May; 20(3):604-14. PubMed ID: 20358439
[TBL] [Abstract][Full Text] [Related]
8. Exposure-response modeling approach for assessing QT effect in "thorough" QT/QTc studies.
Hosmane B; Locke C; Chiu YL
J Biopharm Stat; 2010 May; 20(3):615-31. PubMed ID: 20358440
[TBL] [Abstract][Full Text] [Related]
9. Statistical analysis methods for QT/QTc prolongation.
Ma H; Smith B; Dmitrienko A
J Biopharm Stat; 2008; 18(3):553-63. PubMed ID: 18470763
[TBL] [Abstract][Full Text] [Related]
10. Sample size and power estimation in "thorough" QT/QTc studies with parallel group design.
Hosmane B; Locke C; Chiu YL
J Biopharm Stat; 2010 May; 20(3):578-86. PubMed ID: 20358437
[TBL] [Abstract][Full Text] [Related]
11. Bias and variance evaluation of QT interval correction methods.
Wang Y; Pan G; Balch A
J Biopharm Stat; 2008; 18(3):427-50. PubMed ID: 18470754
[TBL] [Abstract][Full Text] [Related]
12. Comparison of six commonly used QT correction models and their parameter estimation methods.
Wang D; Taubel J; Arezina R
J Biopharm Stat; 2012; 22(6):1148-61. PubMed ID: 23075014
[TBL] [Abstract][Full Text] [Related]
13. Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.
Markert M; Shen R; Trautmann T; Guth B
J Pharmacol Toxicol Methods; 2011; 64(1):25-41. PubMed ID: 21635956
[TBL] [Abstract][Full Text] [Related]
14. Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events.
Molnar J; Zhang F; Weiss J; Ehlert FA; Rosenthal JE
J Am Coll Cardiol; 1996 Jan; 27(1):76-83. PubMed ID: 8522713
[TBL] [Abstract][Full Text] [Related]
15. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
[TBL] [Abstract][Full Text] [Related]
16. Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients.
Nakao S; Hatano K; Sumi C; Masuzawa M; Sakamoto S; Ikeda S; Shingu K
Anesth Analg; 2010 Mar; 110(3):775-9. PubMed ID: 20185656
[TBL] [Abstract][Full Text] [Related]
17. Multiple comparisons of repeatedly measured response: issues of validation testing in thorough QT/QTc clinical trials.
Tsong Y; Yan LK; Zhong J; Nie L; Zhang J
J Biopharm Stat; 2010 May; 20(3):654-64. PubMed ID: 20358443
[TBL] [Abstract][Full Text] [Related]
18. Use of the average baseline versus the time-matched baseline in parallel group thorough QT/QTc studies.
Meng Z; Quan H; Fan L; Kringle R; Sun G
J Biopharm Stat; 2010 May; 20(3):665-82. PubMed ID: 20358444
[TBL] [Abstract][Full Text] [Related]
19. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
20. Assessing QT prolongation and electrocardiography restitution using a beat-to-beat method.
Fossa AA; Zhou M
Cardiol J; 2010; 17(3):230-43. PubMed ID: 20535712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
